The U.S. Food and Drug Administration building in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times
The Food and Drug Administration has halted a program that allowed the transfer of U.S. citizens’ biological samples to China and other “hostile countries.”
The FDA’s ban and review are a necessary move to bolster U.S. biosecurity against the potential threat of biological warfare and bioterror by the Chinese Communist Party (CCP), said experts who spoke with the Chinese-language edition of The Epoch Times.
